 |
BioWorld-International-2007-06-06
Bavarian's Smallpox Vaccine Pact Worth Up To $1.6 Billion
Bavarian's Smallpox Vaccine Pact Worth Up To $1.6 Billion
Bavarian Nordic A/S could earn a total of $1.6 billion from its contract with the U.S. Department of Health and Human Services to supply a stockpile of next-generation safe smallpox vaccines. (BioWorld International)